【レポートの概要(一部)】
01. Executive Summary
02.List of Abbreviations
03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04.Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05.Introduction
06.Disease Overview
06.1 Understanding the Disease
06.2 Pathophysiology
06.3 Epidemiology
06.4 Diagnosis
06.4.1 Immunohistochemistry
06.4.2 FISH
06.4.3 SPoT-Light HER2 CISH Test (Subtraction Probe Technology Chromogenic In Situ Hybridization)
06.4.4 Inform HER2 Dual ISH Test (Inform Dual In Situ Hybridization)
06.5 Management
06.5.1 Surgery
06.5.2 Radiotherapy
06.5.3 Chemotherapy
06.5.4 Targeted Therapy
06.5.5 Hormonal Therapy
06.6 Economic Burden
07.Pipeline Analysis
08.Market Landscape
08.1 Market Overview
08.2 Market Size and Forecast
08.3 HER-2 Positive Breast Cancer Market in US
08.3.1 Market Size and Forecast
08.4 HER-2 Positive Breast Cancer Market in EU
08.4.1 Market Size and Forecast
08.5 Five Forces Analysis
09.Market Segmentation by Type of Therapy
09.1 Chemotherapy
09.1.1 Alkylating agents
09.1.2 Antimetabolites
09.1.3 Cytotoxic antibiotics
09.1.4 Taxanes
09.2 Targeted Therapy
09.3 Hormone Therapy
10.Market Segmentation by Molecule Type
10.1 Biologics
10.2 Small Molecules
11.Market Segmentation by Route of Administration
11.1 Oral
11.2 Parenteral
12.Geographical Segmentation
13.Buying Criteria
14.Market Growth Drivers
15.Drivers and their Impact
16.Market Challenges
17.Impact of Drivers and Challenges
18.Market Trends
19.Trends and their Impact
20.Vendor Landscape
20.1 Competitive Scenario
20.1.1 Key News
20.1.2 Mergers and Acquisitions
20.2 Market Share Analysis 2014
20.2.1 Competitive Assessment of the Top Drugs
20.2.2 Celgene
20.2.3 F. Hoffmann-La Roche
20.2.4 GlaxoSmithKline
20.2.5 Novartis
20.2.6 Sanofi
20.3 SWOT Analysis of the Targeted Therapies
20.3.1 Herceptin
20.3.2 Kadcyla
20.3.3 Perjeta
20.3.4 Tykerb
20.4 Other Prominent Vendors
21.Key Vendor Analysis
21.1 Celgene
21.1.1 Key Facts
21.1.2 Business Overview
21.1.3 Business Strategy
21.1.4 Business Segmentation by Revenue
21.1.5 Sales by Geography
21.1.6 Key Information
21.1.7 SWOT Analysis
21.2 F. Hoffmann-La Roche
21.2.1 Key Facts
21.2.2 Business Overview
21.2.3 Business Segmentation
21.2.4 Business Segmentation by Revenue 2012 and 2013
21.2.5 Sales by Geography
21.2.6 Business Strategy
21.2.7 Key Information
21.2.8 SWOT Analysis
21.3 GlaxoSmithKline
21.3.1 Key Facts
21.3.2 Business Overview
21.3.3 Business Segmentation
21.3.4 Business Segmentation by Revenue 2012 and 2013
21.3.5 Sales by Geography
21.3.6 Pipeline Products
21.3.7 Business Strategy
21.3.8 Key Information
21.3.9 SWOT Analysis
21.4 Novartis
21.4.1 Key Facts
21.4.2 Business Description
21.4.3 Business Segmentation
21.4.4 Revenue by Business Segmentation
21.4.5 Revenue Comparison 2012 and 2013
21.4.6 Sales by Geography
21.4.7 Business Strategy
21.4.8 Key Developments
21.4.9 SWOT Analysis
21.5 Sanofi
21.5.1 Key Facts
21.5.2 Business Description
21.5.3 Business Segmentation
21.5.4 Revenue by Business Segmentation
21.5.5 Revenue Comparison 2012 and 2013
21.5.6 Sales by Geography
21.5.7 Business Strategy
21.5.8 Key Developments
21.5.9 SWOT Analysis
22.Other Reports in this Series
[List of Exhibits]
Exhibit 1: Market Research Methodology
Exhibit 2: Executive Summary of Global HER-2 Positive Breast Cancer Market 2015-2019
Exhibit 3: Pathophysiology: HER-2 Positive Breast Cancer
Exhibit 4: Prevalence Data of HER-2 Positive Breast Cancer in the US, 2014
Exhibit 5: Diagnosis of HER-2 Positive Breast Cancer: IHC
Exhibit 6: Diagnosis of HER-2 Positive Breast Cancer: FISH
Exhibit 7: Management of HER-2 Positive Breast Cancer
Exhibit 8: ASCO Treatment Guidelines: HER-2 Positive Breast Cancer
Exhibit 9: Snapshot of Economic Burden of the HER-2 Positive Breast Cancer Market in US
Exhibit 10: Pipeline Snapshot: Combination Therapies
Exhibit 11: Pipeline Snapshot: Therapeutic Vaccines
Exhibit 12: Snapshot of Global HER-2 Positive Breast Cancer Market 2014
Exhibit 13: Global HER-2 Positive Breast Cancer Market 2014-2019 (US$ million)
Exhibit 14: Drivers and Challenges of the Global HER-2 Positive Breast Cancer Market
Exhibit 15: HER-2 Positive Breast Cancer Market in US 2014-2019 (US$ million)
Exhibit 16: HER-2 Positive Breast Cancer Market in EU 2014-2019 (US$ million)
Exhibit 17: Global HER-2 Positive Breast Cancer Market Segmentation by Type of Therapy
Exhibit 18: Global HER-2 Positive Breast Cancer Market Segmentation by Type of Therapy 2014
Exhibit 19: Global HER-2 Positive Breast Cancer Market Segmentation by Molecule Type
Exhibit 20: Global HER-2 Positive Breast Cancer Market Segmentation by Molecule Type 2014
Exhibit 21: Global HER-2 Positive Breast Cancer Market Segmentation by Route of Administration
Exhibit 22: Global HER-2 Positive Breast Cancer Market Segmentation by Route of Administration 2014
Exhibit 23: Geographical Segmentation of Global HER-2 Positive Breast Cancer Market 2014
Exhibit 24: 5-Year Survival Rate by Stage of Diagnosis (SEER analysis for 2004-2010)
Exhibit 25: Revenue Comparison of Top Drugs for HER-2 Positive Breast Cancer in 2013 (US$ million)
Exhibit 26: Product Portfolio: Celgene
Exhibit 27: YoY Growth Rate and Global Revenue of Abraxane 2010-2013 (US$ million)
Exhibit 28: Product Portfolio: F. Hoffmann-La Roche
Exhibit 29: YoY Growth Rate and Revenue of Herceptin 2010-2013 (US$ million)
Exhibit 30: Revenue of Perjeta for 2012-2013 (US$ million)
Exhibit 31: YoY Growth Rate and Revenue of Xeloda 2010-2013 (US$ million)
Exhibit 32: Product Portfolio: GlaxoSmithKline
Exhibit 33: YoY Growth Rate and Revenue of Tykerb 2010-2013 (US$ million)
Exhibit 34: Product Portfolio: Novartis
Exhibit 35: YoY Growth Rate and Revenue of Femara 2010-2013 (US$ million)
Exhibit 36: Product Portfolio: Sanofi
Exhibit 37: YoY Growth Rate and Global Revenue of Taxotere 2010-2013 (US$ million)
Exhibit 38: Herceptin: SWOT Analysis
Exhibit 39: Kadcyla: SWOT Analysis
Exhibit 40: Perjeta: SWOT Analysis
Exhibit 41: Tykerb: SWOT Analysis
Exhibit 42: Celgene: Business Segmentation by Revenue 2011-2013 (US$ million)
Exhibit 43: Celgene: Sales by Geography 2013
Exhibit 44: Business Segmentation of F. Hoffmann-La Roche Ltd. 2013
Exhibit 45: F. Hoffmann-La Roche Ltd.: Business Segmentation by Revenue 2012 and 2013
Exhibit 46: F. Hoffmann-La Roche Ltd.: Sales by Geography 2013 (Pharmaceuticals Division)
Exhibit 47: F. Hoffmann-La Roche Ltd.: Sales by Geography 2013 (Diagnostics Division)
Exhibit 48: GlaxoSmithKline: Business Segmentation 2013
Exhibit 49: GlaxoSmithKline: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 50: GlaxoSmithKline: Sales by Geography 2013
Exhibit 51: GlaxoSmithKline: Pipeline Products 2013
Exhibit 52: Novartis AG: Business Segmentation
Exhibit 53: Novartis AG: Revenue by Business Segmentation 2013
Exhibit 54: Novartis AG: Revenue by Business Segmentation 2012 and 2013 (US$ million)
Exhibit 55: Novartis AG: Revenue by Geographical Segmentation 2013
Exhibit 56: Sanofi SA: Business Segmentation
Exhibit 57: Sanofi SA: Revenue by Business Segmentation 2013
Exhibit 58: Sanofi SA: Revenue by Business Segmentation 2012 and 2013 (US$ million)
Exhibit 59: Sanofi SA: Sales Revenue by Geographical Segmentation 2013
【レポート販売概要】
■ タイトル:HER2陽性乳がん治療の世界市場:化学療法、標的治療、ホルモン療法■ 英文:Global HER-2 Positive Breast Cancer Market 2015-2019
■ 発行日:2015年3月4日
■ 調査会社:Technavio
■ 商品コード:IRTNTR5462
■ 調査対象地域:グローバル
- 分子診断の世界市場分析:製品別、テストロケーション別(Poc、中央検査室)、技術別(PCR、原位置ハイブリダイゼーション、INAAT、マイクロアレイ、MS、NGS、TMA))、用途別(腫瘍、乳がん、前立腺がん、子宮頸がん、薬理ゲノム学、感染症、MRSA、C。ディフィシル、バンコマイシン耐性腸球菌、カルバペネム耐性、インフルエンザ、RSV、カンジダ、結核、髄膜炎、GITテスト、クラミジア、淋病、HIV、HCV、HBV 、遺伝学、神経学、心臓血管)、セグメント予測Global molecular diagnostics market is expected to reach over USD 17.9 billion by 2024, based on a new report by Grand View Research, Inc. Increasing prevalence of infectious diseases including human papillomavirus and influenza is expected to be the primary driving force for the growth of the molecular diagnostics market. In the underdeveloped regions of Africa and Nigeria, other infections, such …
- 世界のパソコン市場動向Following the recently ended replacement of commercial models, global PC market is expected to witness another setback. Coupled with a higher baseline in 2014, notebook PCs and desktop PCs have both witnessed significant declines in 2015. This report provides an overview of the global PC system market, mainly notebook PCs, desktop PCs, and tablets, andmarket volume forecast for the period 2015-201 …
- 世界の産業用マイクロコントローラ及びDSC市場動向(2012-2016)TechNavio’s analysts forecast the Global Industrial Microcontrollers and DSC market to grow at a CAGR of 10.4 percent CAGR over the period 2012-2016. One of the key factors contributing to this market growth is the increased need for enhancing productivity. The market has also been witnessing an increased focus on energy management. However, the increasing complexity in developing intelligent syst …
- エポキシ化大豆油(ESBO)の世界市場ESBO is majorly used as a plasticizer and stabilizer for PVC compounds and gradually evolved its reach to other application segments. The demand for ESBO is high as it has excellent compatibility and thermal stability. ESBO is being used as the preferred substitute for phthalate plasticizers by major PVC manufacturers and suppliers globally. The North America region is the largest consumer of ESBO …
- 世界の加工家きん肉・家きん肉加工機械市場動向及び予測(~2018)The report “Processed Poultry Meat & Poultry Processing Equipment Market By Types (Chicken, Turkey, Ducks), By Product Type (Fresh Processed, Raw-Cooked, Pre-Cooked, Raw-Fermented, Cured, Dried), By Equipment Type & By Geography-Global Trends & Forecasts to 2018”categorizes global processed poultry meat based on product types,meattypes, geography, andmeat processing equipmentmarket based on types …
- マイクログリッド向けエネルギー貯蔵の世界市場About microgrids Microgrids are remote grids that can operate independently from conventional grid networks. They have control capabilities and are geared to connect to a main grid at a point of coupling that can maintain the voltage at the same levels as the main grid. These grids are also capable of negating instabilities by enabling the deployment of renewable energy sources such as solar PV an …
- インスリン非依存型糖尿病治療薬の世界市場2018-2022About Non-insulin Diabetes Therapeutics Non-insulin diabetes therapeutics are mostly administered orally and prescribed when diet and exercise are insufficient to control elevated blood glucose levels. Technavio’s analysts forecast the global non-insulin diabetes therapeutics market to grow at a CAGR of 11.37% during the period 2018-2022. Covered in this report The report covers the present scenar …
- 中国のEV充電スタンド市場2016-2020About the Electric Vehicle Charging Station Market in China China has been aggressive in its efforts to promote EV adoption, primarily to cope with the growing pollution scenario. China was placed at the top of the nations with the most carbon dioxide emissions in 2011. China’s tremendous economic growth has been riding on the country’s manufacturing sector, which has been a key contributor to the …
- 睡眠無呼吸症用医療機器の世界市場:睡眠無呼吸治療デバイス、睡眠無呼吸診断デバイスThe global sleep apnea devices market is expected to grow at a CAGR of 16.6% during the forecast period of 2014 to 2019. North America is the largest market in the global sleep apnea devices market, with a market share of 51.8% as of 2013, followed by Europe and Asia. The largest share of the North American segment is associated with various driving forces, such as the increasing patient pool of s …
- Cachexia:グローバル臨床試験レビューH2, 2013Cachexia Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Cachexia Global Clinical Trials Review, H2, 2013" provides data on the Cachexia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cachexia. It includes an overview of the trial numbers and their recruitment status as per the site of trial condu …
- ガス化技術の世界市場2015-2019About Gasification Gasification is a thermochemical process that converts hydrocarbons such as coal, petroleum, petcoke, natural gas, and biomass into simple molecules, primarily resulting in a mixture called syngas (carbon monoxide and hydrogen) by means of partial oxidation with air, oxygen, or steam. The key advantage of gasification is its ability to perform in various designs having a reduced …
- 変流器(CT)の世界市場2017-2021ABSTRACTAbout Current Transformers Current transformers find applications in alternating current (AC) systems where they are used to measure current. To protect the electrical system, current transformers are often used with protective relays incorporated into the network. The operating current levels of any electrical system are high and it becomes difficult to measure the current due to the lack …
- 世界のナイロン・フィルタ市場2015The Global Nylon Filter Industry Report 2015 is a professional and in-depth study on the current state of the Nylon Filter industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Nylon Filter market analysis is provided for the international markets including development trends, competitive landscape anal …
- ヘッドセットの世界市場分析:製品別(インイヤー、オーバーイヤー)、価格別(USD50未満、USD50~100、USD100以上)、技術別(ワイヤー式、ワイヤレス)、用途別(個人用、商業用)、セグメント予測The headsets market is estimated to reach approximately USD 20,465.7 million by 2024, according to a new study conducted by Grand View Research, Inc. The rise in the disposable income is remarkably driving the demand for application-specific headsets. The increase in consumer spending for consumer electronic products has significantly spurred the market growth. The growing demand for improved desi …
- 提案管理ソフトウェアの世界市場予測:ソフトウェア別、サービス別、展開種類別、組織規模別Increasing shift to cloud-based technologies is driving the proposal management softwareMarketsandMarkets projects the global proposal management software market size to grow from USD 1.5 billion in 2019 to USD 3.1 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 14.9% during the forecast period. Major factors expected to drive the growth of the proposal management software market inclu …